Insider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Insider Sells 6,500 Shares of Stock

Scholar Rock Holding Co. (NASDAQ:SRRK) insider Tracey Sacco sold 6,500 shares of the company’s stock in a transaction on Monday, March 24th. The stock was sold at an average price of $33.08, for a total transaction of $215,020.00. Following the completion of the sale, the insider now owns 71,750 shares of the company’s stock, valued at $2,373,490. This represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Scholar Rock Stock Down 1.6 %

Shares of SRRK stock opened at $33.28 on Wednesday. Scholar Rock Holding Co. has a 12 month low of $6.76 and a 12 month high of $46.98. The company has a quick ratio of 3.88, a current ratio of 3.88 and a debt-to-equity ratio of 0.63. The firm has a market cap of $3.15 billion, a PE ratio of -14.16 and a beta of 0.59. The stock has a 50 day moving average of $38.40 and a 200-day moving average of $32.72.

Hedge Funds Weigh In On Scholar Rock

Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC grew its position in Scholar Rock by 51.8% in the 4th quarter. GAMMA Investing LLC now owns 788 shares of the company’s stock worth $34,000 after purchasing an additional 269 shares during the last quarter. JPMorgan Chase & Co. grew its position in Scholar Rock by 1.0% during the third quarter. JPMorgan Chase & Co. now owns 38,726 shares of the company’s stock worth $310,000 after buying an additional 379 shares in the last quarter. Amalgamated Bank grew its position in Scholar Rock by 30.6% during the fourth quarter. Amalgamated Bank now owns 2,643 shares of the company’s stock worth $114,000 after buying an additional 620 shares in the last quarter. Global Retirement Partners LLC increased its stake in Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company’s stock valued at $39,000 after acquiring an additional 766 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in shares of Scholar Rock by 1,321.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,109 shares of the company’s stock worth $48,000 after acquiring an additional 1,031 shares during the period. 91.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on SRRK shares. Wedbush reiterated an “outperform” rating and set a $50.00 price target on shares of Scholar Rock in a research note on Tuesday. HC Wainwright upped their target price on Scholar Rock from $40.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Scholar Rock has an average rating of “Buy” and a consensus price target of $40.86.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.